StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by LithLoveron Mar 06, 2023 1:31pm

138 Views

Post# 35321776

New post -Women's cancers

Posted a few minutes ago:
StageZero Life Sciences Ltd. (TSX: SZLS)

March is Women's History Month, a time to celebrate the achievements and contributions of women throughout history. But as we honor the women of the past, we must also protect women's futures. Early detection is critical to successfully treating women's cancers such as #ovariancancer, #breastcancer, #endometrialcancer, #bladdercancer and #cervicalcancer. StageZero’s ARISTOTLE® test can help detect 8 of the most common cancers in women through a single blood sample. As we celebrate women’s history month, let’s help ensure their future health by making a late-stage cancer diagnosis a thing of the past. https://ow.ly/L4wE50N9aY2

#SZLS #SZLSF #WomensHistoryMonth #EarlyDetectionSavesLives #EarlyMeansEverything
No alternative text description for this image